Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.

@article{Wang2015MulticenterRC,
  title={Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.},
  author={Chunping Wang and Huaming Wang and Wuwei Yang and Kaiwen Hu and Hui Xie and Ke-qin Hu and Wenlin Bai and Zheng Dong and Yin-ying Lu and Zhen Zeng and M. I. Mill{\'a}n Lou and Hong Wang and Xudong Gao and Xiujuan Chang and Linjing An and Jianhui Qu and Jin Li and Yongping Yang},
  journal={Hepatology},
  year={2015},
  volume={61 5},
  pages={1579-90}
}
UNLABELLED Radiofrequency ablation (RFA) is considered a curative treatment option for hepatocellular carcinoma (HCC). Growing data have demonstrated that cryoablation represents a safe and effective alternative therapy for HCC, but no randomized controlled trial (RCT) has been reported to compare cryoablation with RFA in HCC treatment. The present study was a multicenter RCT aimed to compare the outcomes of percutaneous cryoablation with RFA for the treatment of HCC. In all, 360 patients with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
40 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey

  • M1 Pompili, A Saviano, N de Matthaeis, A Cucchetti, F Ardito, B Federico
  • J Hepatol
  • 2013

Similar Papers

Loading similar papers…